Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Genentech licenses TPO to Pharmacia & Upjohn

Jan. 9, 1998

No Comments

Cell Therapeutics and City of Hope join forces for diabetes research

Jan. 9, 1998

No Comments

Phase II results presented for BB-10010

Jan. 8, 1998

No Comments

Bayer announces copromotion agreement for cerivastatin

Jan. 8, 1998

No Comments

Cell Genesys to receive milestone payment from HMR for GA-EPO

Jan. 7, 1998

No Comments

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Jan. 7, 1998

No Comments

Native calcitonin mimetics from ZymoGenetics

Jan. 5, 1998

No Comments

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Jan. 2, 1998

No Comments

Akzo Nobel describes new gonadotropins with therapeutic potential

Jan. 2, 1998

No Comments

OGT-918 clinical development program begins

Dec. 30, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Genentech licenses TPO to Pharmacia & Upjohn

Cell Therapeutics and City of Hope join forces for diabetes research

Phase II results presented for BB-10010

Bayer announces copromotion agreement for cerivastatin

Cell Genesys to receive milestone payment from HMR for GA-EPO

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Native calcitonin mimetics from ZymoGenetics

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Akzo Nobel describes new gonadotropins with therapeutic potential

OGT-918 clinical development program begins

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS